PaTHway Phase 3 Trial Analysis

Calcium Supplement Dose (Mean +/- SE) by Visit 3000 2500 Calcium Dose 2000 mg/day 1500 Mean (± SE) 1000 500 18 HHIA HH HH HH ратнішач TRIAL TransCon PTH Placebo - 8 12 16 20 24 28 Weeks TransCon PTH enabled rapid and sustained calcium supplement reduction TransCon PTH is an investigational product candidate. For investor communication only. Not for use in product promotion. Not for further distribution. ascendis pharma

View entire presentation